Vetsonic UK has announced the addition to its range of Vetericyn Super 7+, a brand new umbilical cord dry-out solution for use in calves, lambs, piglets, foals, kids and puppies which is designed as an alternative to iodine.
Vetsonic says that because Super 7+ contains no iodine, it won't encourage licking by iodine-deficient mothers, which can cause serious damage to the navel. It is also an ideal alternative for handlers who are prone to iodine allergies.
The company points to a US study conducted by Auburn University in which Super 7 + demonstrated more than double the desiccation efficacy in the first 24 hours when compared to 7% tincture of iodine.
Super 7+ contains a dye for easy identification of treated animals and the company says it is environmental friendly, safe, non-flammable and non-corrosive with no toxic fumes.
Super 7 + is now available through veterinary wholesalers and direct from Vetsonic (UK) Ltd, either in a 500 ml spray bottle (box of 6) or a 3.78 litre bottle for dipping.
For more information, visit www.vetsonic.com
Idexx has launched Pet Resist (www.petresist.com), an online map of the levels of antibiotic resistance recorded in cats and dogs by the company over the past five years.
The map displays geographical variations in resistance to the top 10 antibiotics used in cats and dogs.
Simon Wootton, UK CAG Marketing Manager from Idexx said: "The ability to select the most appropriate antibiotic prior to testing may increase the effectiveness of treatments and reduce the number of return visits. We believe that this new service will also help prolong the effective life of existing antibiotics at a time when there is considerable pressure on the profession to reduce their use."
Pet Resist shows levels of resistance overlaid on an interactive UK map down to individual postcode areas. You enter the postcode, the antibiotic (amoxicillin, ampicillin, cefaliexn, etc) and the suspected organism (E coli, S aureus, etc), after which you'll be able to see the level of resistance based on historical data from the past five years, and use this to help choose appropriate therapies.
Simon added: "We have used results of MIC tests on over 200,000 samples submitted to Idexx to develop the database upon which the resistance levels are based. The data will be continually updated as we receive more samples at our Wetherby laboratory, further increasing the accuracy and value of the service to vets and their clients."
The new editorial team is comprised of Gareth Arthurs and Rob Pettitt, both RCVS Recognised Specialists in Small Animal Surgery (Orthopaedics) and Gordon Brown (no, not that one), an RCVS Diplomate in Small Animal Surgery (Orthopaedics).
Given the considerable evolution in the diagnosis, understanding and treatment options for many orthopaedic disorders, this second edition includes the investigation of lameness, including the use of force plates and kinematics, the current understanding of elbow dysplasia and the wide array of available treatment options, and diagnostic and surgical arthroscopy.
New, advanced surgical techniques, such as tibial osteotomy for cranial cruciate ligament disease, cementless total hip replacement for hip dysplasia and replacement of the trochlear sulcus for patellar luxation have been covered, together with guidance on the level of training and experience necessary to achieve consistently good results.
The manual is divided into four principle sections:
Lameness investigation
Musculoskeletal disorders
Principles of orthopaedic surgery
Management of specific disorders, ordered by individual joints.
The joint-specific chapters all follow a similar format, comprising the main chapter and then, where relevant, imaging and operative techniques.
Gareth Arthurs, one of three editors, said: "We feel privileged to have worked with such a broad range of talented authors whose combined international skills, knowledge and experience is impressive and very difficult to match. It has truly been a privilege to work with such a team of inspiring veterinary surgeons with expertise in various fields, and we are confident that the talent of each individual shines through their chapter".
The second edition of the BSAVA Manual of Canine and Feline Musculoskeletal Disorders is available from the BSAVA website: www.bsava.com or by phone: 01452 726700. The online edition is available from: www.bsavalibrary.com
The RCVS Disciplinary Committee has agreed to adjourn multiple charges against a County Durham-based veterinary surgeon following her undertakings to request removal from the RCVS Register and never to apply to be restored to it.
At the hearing held yesterday, Silke Birgitt Lindridge was charged with disgraceful conduct in a professional respect in regard to four separate allegations, spanning the period of June 2011 to September 2012 whilst in practice at the Safe Hands Veterinary Group. Two of the allegations related to failures to euthanase or arrange the euthanasia of a cat and a dog and being dishonest and/or misleading about these failures, with their respective owners. The other two allegations related to administering a vaccine (Fevaxyn) which was more than two years past its expiry date to a cat, and failure to provide or take adequate steps to provide promptly all the relevant clinical information to a veterinary practice taking over the responsibility for the treatment of a Labrador Cross.
However, before the Disciplinary Committee had heard evidence in respect of these charges, Mrs Lindridge, who did not attend the hearing, had lodged her application for adjournment on the basis that she would request that the Registrar remove her name from the Register with immediate effect and undertake never to apply to be restored to it. The Disciplinary Committee made no enquiry into the facts of the four charges and emphasised that they had neither been proved against, nor admitted by, the respondent.
Removal from the RCVS Register removes a veterinary surgeon's right to practise in the UK. The respondent informed the RCVS that she had no wish to return to the practice of veterinary surgery in this country. Should she subsequently apply to be restored to the Register, the Disciplinary Committee would resume its consideration of the charges, along with the breach of her undertaking.
The Disciplinary Committee was advised that the views of the animal owners involved had been sought and that all had agreed with the proposed course of action.
Speaking on behalf of the Disciplinary Committee, its Chairman, Professor Peter Lees, said: "Having considered the information before it, the Committee has decided it would not be in the public interest to proceed to a full hearing. It is satisfied that the undertakings offered by the respondent [Mrs Lindridge] protect the welfare of animals and uphold the reputation of the profession."
Professor Lees added: "The undertakings offered by the respondent to request the Registrar to remove her name from the Register with immediate effect and never to make an application for restoration to the Register, go beyond any sanction that this Committee could impose at the conclusion of a contested hearing. It does not consider that it would be proportionate for either party to incur the substantial costs of a contested hearing."
The Disciplinary Committee has directed that Kfir Segev be restored to the RCVS Register, having removed him over two years ago for dishonesty and misleading clients.
Mr Segev, formerly practising in Stanmore, Middlesex, was removed from the Register following an 11-day hearing ending on 19 May 2009 at which he had been proven guilty of deliberately concealing from his clients that their dog was terminally ill, whilst at the same time recommending that she undergo expensive and unnecessary procedures.
This was Mr Segev’s first application for restoration to the Register. The Committee found that, during his period of removal, he had undergone “extensive personal and professional rehabilitation”, which included attendance at a clinical psychologist and voluntary work in the local community.
The Committee found that, during his period of removal, he had undergone "extensive personal and professional rehabilitation.
From 2009 to September 2011, Mr Segev logged 420 hours of certificated continuing professional development, with particular emphasis on ethics, client relationships and animal welfare.
The Committee noted he had also seen practice and taken the advice of mentors, including about 80 days at “a number of high quality practices with eminent members of the profession”.
These included Professor Dick White MRCVS, of Dick White Referrals, Professor David Noakes FRCVS, Emeritus Professor of the Royal Veterinary College and Mr David Grant MBE FRCVS, Hospital Director at the RSCPA Sir Harold Harmsworth Memorial Hospital, all of whom gave evidence at the hearing in support of Mr Segev.
Professor White said that, since late 2009 when he was approached by Mr Segev for help in remedial training, continuing education and mentoring, he had subsequently had frequent dealings and conversations with him.
Professor White said: “I formed the opinion that he invariably exercised professional clinical judgement that is, if anything, considerably deeper than many professional colleagues. I felt he demonstrated compassion for patients and empathy for owners in equal measure and believed him to have come to understand fully the seriousness of his behaviour."
Mr Segev’s efforts at rehabilitation were described as “exceptional” by Professor Noakes, who said he was “impressed by Mr Segev’s genuine acceptance of the fact that he had committed a serious offence and deserved to be punished.”
Mr Grant, who had been in contact with Mr Segev since November 2010, told the hearing that, in his opinion, it was most evident that Mr Segev accepted his wrongdoing and, along with Professor Noakes, indicated that he was willing to offer continued support and help.
The College opposed the restoration of Mr Segev on three grounds, namely: the gravity of the matters found proved at the original hearing; that the length of time off the Register was insufficient to mark these and ensure that the reputation of the profession was not undermined in the eyes of the public; and, Mr Segev’s conduct, relying on two matters arising from the footage in a BBC Panorama programme, which was filmed both before and after the 2009 hearing.
The College also questioned whether Mr Segev genuinely accepted the original findings.
The Committee agreed that the findings of the original hearing were serious; it was, however, impressed by Mr Segev’s complete and genuine written and public apologies for what he had done.
It disagreed that the length of time off the Register was too short.
It was mindful that the purpose of the sanction of erasure is not primarily of punishment and considered that no useful purpose would be served by delaying further Mr Segev’s restoration.
Whilst the Committee found Mr Segev was wrong to have continued to display ‘veterinary surgeon’ on the practice nameplate (as shown in the television footage), it was satisfied that he did not intend to hold himself out as a practising veterinary surgeon and no harm to the public or animal welfare resulted from his mistake.
The footage also showed Mr Segev was in breach of RCVS guidance on the administration of anaesthesia by permitting a student veterinary nurse to induce anaesthesia by using incremental doses of intravenous propofol, with an unqualified assistant offering advice on the depth of anaesthesia during its incremental induction. The Committee considered Mr Segev’s actions to be an error, now cured.
In conclusion, the Committee accepted Mr Segev “had made genuine and successful attempts to reform his previous attitude and failings”.
It noted that a large number of testimonials had been provided by colleagues, friends and clients, and that the impact of removal on Mr Segev had been severe.
It concluded that his previous mistakes provided “no reason, relevant to animal welfare, to suggest that his restoration would be unwise.”
Speaking on behalf of the Committee, Chairman Beverley Cottrell said: “Restoration to the Register of a veterinary surgeon who has been guilty of disgraceful conduct in a professional respect of such seriousness is not something to be undertaken lightly … But, in all the circumstances of this case, [we have] decided that Mr Segev is a fit person to restore to the Register, and so direct the Registrar.”
Ceva Animal Health has launched Hepatosyl Plus, a development of the liver support supplement for cats and dogs.
Hepatosyl Plus contains the same ingredients as the original product but now also includes Silybin. According to the company, Silybin is the most active isomer of Silybum marianum (milk thistle) which acts as an antioxidant by increasing cellular superoxide dismutase. It joins S-adenosylmethionine (SAMe) and Vitamin E to create a triple antioxidant approach to liver support, helping to neutralise free radicals within the liver. Ceva also says Hepatosyl Plus is the only liver supplement to contain Vitamin K, which is needed by the liver for the production of clotting factors II, VII, IX and X, making it ideally suited for pre- and post-anaesthetic liver support.
Hepatosyl Plus is available in 50mg, 100mg and 200mg sprinkle capsules. For anaesthetic support, Hepatosyl Plus should be administered for one week prior to and following anaesthesia. For long-term use, the capsules should be given once daily for 2-3 months and then reduced to every other day for ongoing maintenance.
For further information, please contact your local CEVA Animal Health territory manager or call 01494 781510.
Bonqat 50 mg/ml oral solution for cats contains pregabalin, an analgesic, anti-epileptic which has now been licensed for the alleviation of acute anxiety and fear associated with transportation and veterinary visits in cats.
Tessie 0.3 mg/ml oral solution for dogs contains tasipimidine and is licensed for the short-term alleviation of situational anxiety and fear in dogs triggered by noise or owner departure.
Dômes Pharma points to research which shows that in the UK 1.4 million1 dogs show signs of distress when left alone, and 4.4 million dogs1 show fear of loud noises.
In addition, over 4 million cats2 are not having routine vet checkups each year, with 26%2 of these owners reporting that it is too stressful for their cat or themselves.
Jonathan Hill, UK country manager at Dômes Pharma sid: "Dômes Pharma is excited to be launching two new innovative products to help vets manage cases in this complex area.
"These products expand our portfolio and provide essential options for owners and their pets struggling with these situational related problems."
https://www.tvm-uk.com/the-behavioural-range
Reference
Pete (pictured right), an RCVS Recognised Specialist in Veterinary Dentistry, was recognised for his outstanding contributions to the discipline of veterinary oral and maxillofacial surgery (OMFS).
There are a total of 14 founding fellows and Pete is the only one practising in Europe. The award will mean it’s possible for an OMFS Fellowship programme to be delivered at Eastcott Referrals in the future.
Pete said: "To be accepted as an AVDC Fellow is a real honour and I’m delighted to be awarded this position. There is a pretty rigorous process to go through to become a Founding Fellow of the AVDC, so it’s extremely gratifying to be recognised."
At the same time, another Eastcott clinician is also celebrating recognition in the same discipline: Andrew Perry has become a European Veterinary Specialist in Dentistry.
Pete said: "We all congratulate Andrew on his achievement. He is a hugely valuable and experienced member of the team here.
"It’s a very exciting time for Eastcott, as we seek to expand our dentistry and oral and maxillofacial surgery department and develop new techniques in OMFS.
"We have a highly experienced team and will adding another Resident in the new year, so we’re in an extremely strong position to deal with a large caseload and able to see a wide range of different cases."
For more information about Eastcott Referrals, visit www.eastcottreferrals.co.uk.
Eurovet has launched Relaquine 35 mg/ml Oral Gel for Horses - a licensed acepromazine (ACP) in a gel format.
The company says Relaquine can be used to sedate horses for examination and in stressful situations that some horses find hard to deal with such as farriery, box rest, dentistry and clipping where highly-strung horses can cause problems. Relaquine is administered orally or mixed with food and is available as an adjustable syringe format containing 10 ml of gel.
Relaquine is the fourth product launch this year by Eurovet and the company says there is more in the pipeline for 2011.
Relaquine Oral Gel is expected to be available to order from veterinary wholesalers from Monday 16th May. Eurovet is also offering an introductory promotion: for further details contact Eurovet on 01223 257933.
The charity, which was set up over 120 years ago, says the number of calls and emails it gets from industry professionals seeking help has increased 500% over the last 5 years; it has received more than 1,500 calls and emails over the past 12 months.
Lynne Hill, Chief Executive of Linnaeus said: "The veterinary industry is fast-paced and, at times, an extremely stressful environment, so the support on offer from Vetlife is particularly valuable and its worth is demonstrated by the significant increase in contact being made to it.
"We hope this donation will help Vetlife continue to provide the excellent service and support they have given to vets and nurses for so long."
Vetlife President Geoff Little said: "This donation from the Linnaeus Group is extremely generous. We have seen a dramatic rise in calls and emails to the service over recent years. So much so, we have recruited additional volunteers to cope with the additional contacts. It’s extremely gratifying to see the number of volunteers who are so willing to put something back into their profession and to help others.
"At Vetlife, we provide support in the shape of three core services, which are the Vetlife Helpline, which provides independent, confidential support 24/7, 365 days a year; Health Support, run by mental health professionals; and Financial Support, which provides assistance to vets or their dependents who find themselves in difficulty.
"This support from Linnaeus will help us to bridge the gap as the need for support continues to grow."
Anyone who needs support can contact the Vetlife Helpline on 0303 040 2551 or anonymously via www.vetlife.org.uk.
Photo: Vetlife President Geoff Little receives the £60,000 donation from Lynn Hill at Linnaeus.
MSD says the new vaccine reduces the clinical signs of respiratory disease and viral shedding from infection with Bovine Respiratory Syncytial Virus (BRSV) and Parainfluenza-3 Virus (Pi3V), and that no other UK-licensed BRD vaccine can be administered earlier in life.
According to the company, it also delivers the fastest on-farm protection, with an onset of immunity after administration of 5 days for BRSV and 7 days for Pi3V. The duration of immunity is 12 weeks for both viruses.
MSD Animal Health ruminant veterinary adviser Dr Kat Baxter-Smith MRCVS said: "Early-age protection of calves through intranasal vaccination can help prevent pneumonia and positively impact a calf’s productive future.
"The sooner and faster these young calves can be protected against viral BRD and the permanent lung damage it causes, the better their potential lifetime productivity, be it in terms of delivering expected milk yield in the dairy herd or growth performance on the beef unit1 2."
Kat added that Bovilis Intranasal RSP Live also activates non-specific immunity – stimulating receptors and cytokines in the innate immune system3: "This equates to protection against viral replication in the nasopharyngeal cavity, reduction of virus shedding and protection of the calf against subsequent clinical symptoms3."
MSD says a practical benefit of Bovilis Intranasal RSP Live to farmers is that it can be used on farm up to six hours after mixing with the solvent, which is the longest of all the available intranasal BRD vaccines. Additionally, the new vaccine is supplied as a farm-friendly, easy-to administer nasal suspension product that doesn’t need a specific applicator – although for maximum flexibility a new easy-clean injector and nozzle kit is available for farmers needing to vaccinate multiple animals.
References:
Dechra says phenobarbital is effective as a monotherapy in 60 to 80 per cent of dogs with idiopathic epilepsy, but that in 40% of dogs, seizures cannot be controlled with phenobarbital alone. In these cases the company's potassium bromide treatment Libromide, is licensed to be used alongside Soliphen as a concurrent therapy.
According to the company, the combination of phenobarbital and potassium bromide has been shown to reduce seizure number and severity in dogs with refractory idiopathic epilepsy; in tests, the combination treatment reduced the mean seizure rate from 27.4 seizures per month to 2.2 seizures.
Dechra Veterinary Products Brand Manager Craig Sankey said: "Epilepsy is the most common chronic canine neurological disorder, affecting around 0.62 per cent of dogs.
"It can be a distressing condition for both the animal and its owner so we are launching a therapy that can reduce the number of seizures in even the most challenging cases.
"We have also produced new guidelines for prescribing vets, detailing step by step how the treatments can act alone or concurrently. We believe using Soliphen as a sole therapy or in conjunction with Libromide will make a positive contribution to veterinary professionals in their ongoing treatment and management of dogs with epilepsy."
For more information, visit www.dechra.co.uk
Novartis Animal Health has announced the launch of Strenzen, an oral water medication for pigs, indicated for the treatment of gastrointestinal infections caused by Escherichia coli, Clostridium perfringens and Salmonella Typhimurium, and for respiratory tract infections caused by Actinobacillus pleuropneumoniae, Pasteurella multocida and Streptococcus suis.
Strenzen contains contains a combination of amoxicillin trihydrate (500 mg/g) and potassium clavulanate (125 mg/g) in ratio of 4:1. Novartis says it is ideally suited for the treatment of post-weaning infections in pigs.
According to the company, the combination of amoxicillin and clavulanic acid broadens the performance of amoxicillin1,2, especially against resistant strains of bacteria capable of producing ß-lactamase enzymes. Certain bacteria are able to produce ß-lactamase enzymes as a protection mechanism, making the amoxicillin molecule ineffective against them. The clavulanic acid in Strenzen binds to the molecules of the ß-lactamase enzyme, ensuring the amoxicillin remains unaffected and free to attack bacteria. Prof. Dominiek Maes, DVM, MSc, MS, PhD, Dipl. ECVPH, Dipl. ECPHM, from the Porcine Health Management Unit of the Ghent University, Belgium said: "Weaning is a stressful event for piglets and there are several opportunistic diseases that can impact them during this period. The challenge with E. coli and S. suis infections is that in many countries there are currently no commercial vaccines available with proper efficacy. I believe Strenzen can indeed be very helpful in managing those infections which are so prevalent after weaning."
Novartis says Strenzen is rapidly excreted, leading to a withdrawal period of one day, which in turn maximizes production flexibility for pig producers. In addition, the water-soluble formulation of Strenzen ensures that treated pigs get a therapeutic dose even when they stop eating, making it an ideal treatment for sick pigs with compromised appetites.
Recent field trials on infected farms in Spain and the Czech Republic demonstrated that Strenzen-treated pigs give better production performance, better economic returns and require less medical intervention3,4,5. The reduction of the overall amount of antibiotics needed to treat severe post-weaning infections not only saves producers the costs of the labour and the medication, but is also important in regard to the development of resistance in bacteria.
Dr. Ulrich Klein, Global Technical Services Manager, Novartis Animal Health said: "With the launch of Strenzen, Novartis Animal Health demonstrates its commitment to continually broadening our product portfolio to address the specific needs of farmers and food producers. Strenzen has the ideal spectrum for the treatment of post-weaning infections, delivering better productivity results than current therapies for those infections."
References
VetSurgeon.org has joined forces with referral practitioner Alex Gough to conduct a survey into the profession's attitude to the use of homeopathy in animals.
Whilst the debate continues to rage over its use in human medicine, this is believed to be the first time that there has been a survey of opinion within the veterinary profession.
Alex Gough said: "This should give us an interesting insight into how practitioners feel about one of the more well-known systems of alternative medicine. That in turn may add something to the broader debate outside the veterinary profession."
Arlo said: "We really need as many veterinary surgeons as possible to take part, in order to get the most accurate picture. There are only 8 questions, and it should take less than a minute."
Click here (veterinary surgeons only), to take part in the survey.
In an internal study, Royal Canin found that Pill Assist Cat achieved over 91% pill acceptance.
Pill Assist Cat is enriched with vitamins and prebiotics to support a cat’s recovery, and each treat contains only three calories.
Elisabete Capitao, Royal Canin Veterinary Marketing Manager said: "We know that getting cats to take pills can be quite a challenge even for the most experienced pet owners! A quarter of owners leave the veterinary clinic with oral medication for their cat, but 40% find giving pills to their cat complicated. Pill Assist Cat makes giving cats medication easy and takes the stress out of pill time."
Royal Canin says Pill Assist Cat is suitable for most types of medication, from worming tablets to medication for an illness.
Domingo, pictured on the left with Southfields clinical director Henry L’Eplattenier, will join the Essex referral centre as head of cardiopulmonary service at the start of February.
After qualifying in Zaragoza in his native Spain, Domingo completed an internship and several years in practice in the UK, before joining the University of Bristol small animal hospital as a resident.
He then completed a three-year training programme in small animal internal medicine, followed by a four-year programme in cardiology to become an RCVS diplomate and specialist in veterinary cardiology and small animal internal medicine (ECVIM).
After being appointed as head of cardiology and respiratory medicine at Bristol, Domingo joined Dick White Referrals before his move to Southfields.
Domingo said: "I’m delighted to be joining such a progressive and forward-thinking practice as Southfields. It is clear everyone at the practice is dedicated to continuing its growth and dedication to providing the highest possible level of care."
Southfields’ operations manager Daniel Hogan said: "The arrival of Domingo adds another hugely talented specialist to our growing team of experts. He is, without doubt, at the top of his profession and his passion and dedication are traits which will fit perfectly at Southfields as we continue to grow."
Domingo is also a visiting lecturer in cardiology and respiratory medicine at the Catholic University of Valencia, while he is an active clinical researcher and has published widely in many areas of cardiology and respiratory medicine. His areas of special interest are arrhythmias and interventional cardiology.
For more information about Southfields Veterinary Specialists, go to www.southfields.co.uk.
The company says that the 20 module medicine programme, covering all of the major body systems of cats and dog, combines the latest thinking in small animal medicine with its world-class learning resources to ensure that delegates’ learning experience online gives the same high-quality learning as the attendance programme.
Improve says it aims to offer a route for veterinary surgeons who don’t have the time to participate in an attendance programme or who work in countries where this type of training is not available, the opportunity to study for a recognised postgraduate qualification.
Delegates signing up for the programme will have a module tutor – an RCVS or ECVIM/ACVIM Small Animal Internal Medicine Diploma holder – and a dedicated programme tutor who works with individual delegates to ensure they are supported throughout the programme.
Improve says the course includes interactive and engaging modules, together with real-life case studies, presentations, written notes, interactive quizzes and exercises.
Dr Alison Babington MRCVS, Business Coordinator at Improve said: "The pressures on veterinary professionals today have never been more intense and many of us struggle to find the work-life balance which is so important for our well-being. Unfortunately, these pressures often preclude many vets from undertaking the type of postgraduate training which could give them additional job satisfaction and enhance both their career prospects and the profitability of their practice.
"It has been our ambition for some time to offer some of our flagship programmes online and, in creating the Distance Learning Small Animal Medicine programme, we drew on the experience of the latest online platforms.
"This new Distance Learning Programme offers a high quality interactive, engaging Small Animal Medicine learning experience which will be fun to study and a far cry from the days of simply reading text online. It will be accessible to vets working anywhere in the world and we’re very proud to be able to offer a high level programme via this learning route."
For more information visit: www.improveinternational.com or ring 01793 759159.
PBD says Bovine tuberculosis (bTB) is a growing problem for zoos and wildlife parks, especially with the disease’s potential to spread from one species to another, creating a natural reservoir that is difficult to control.
bTB in zoos came to public attention last year when Devon’s Paignton Zoo detected a single case in one of its antelope. Without access to a test that would deliver rapid results, the zoo had to cull the remaining 10-strong herd of Kafue Flats lechwe.
PBD says the Actiphage test can identify bTB and other mycobacterial diseases in animals before clinical symptoms of infection are observed. It can detect with high specificity the presence of any mycobacteria in animal blood within 6 hours in comparison to culturing mycobacteria, which can take up to 12 weeks.
The technology has been successfully applied to blood samples from 17 different species so far, including deer, goats and badgers as well as exotic animals such as lions, giraffes, antelopes, elephants, tigers, kangaroos and camels. Trials have confirmed PBD Biotech’s assay can detect live mycobacteria in blood or milk samples at very high sensitivity, of less than 10 mycobacterial cells per ml of sample.
The test is being presented to delegates at the British Veterinary Zoological Society (BVZS) Congress in Birmingham today by Dr Ben Swift, Research Fellow at the Royal Veterinary College and R&D Director at PBD Biotech.
He said: "The Actiphage detection method provides a major step change in the detection of viable mycobacteria and has the potential to revolutionise the control and understanding of mycobacterial diseases in zoo animals, wildlife and a range of other species.
"The use of bacteriophage means the test can detect mycobacteria before an immune response is fully developed, giving vets, zoo-keepers and other exotics experts a head-start on the race to catch bTB and other diseases in the hope of preventing the unnecessary cull of protected animals."
Dechra Veterinary Products has launched Myorelax, a guaifenesin 100 mg/ml solution for infusion for horses which, the company says, relaxes skeletal muscles within minutes.
Dechra's Equine Brand Manager Emma Jennings said: "Myorelax is indicated for the induction of muscle relaxation and immobilisation, as an adjunct to balanced anaesthesia.
"We're delighted to launch this product, which can be combined with a number of sedatives and anaesthetics including detomidine, ketamine and propofol plus local and volatile anaesthetics.
"Myorelax is a centrally acting muscle relaxant which is effective within a few minutes and does not affect the animal's respiratory muscles at therapeutic doses. It can be used in combination with a sedative and local anaesthetics for short procedures and together with appropriate general anaesthetics for induction and maintenance of muscle relaxation during anaesthesia."
Dechra says that horses are able to stand within 45 minutes after single administration, and the product can be used in a 'triple drip' protocol for total intravenous anaesthesia.
Myorelax is available in 500 ml bottles from veterinary wholesalers.
For further information, visit www.dechra.co.uk
Andrew Harrison, a partner at Three Counties Equine Hospital in Gloucestershire, has been appointed as the new President of the British Equine Veterinary Association (BEVA) for 2014/15.
Andrew took over the role from Paul Jepson at the end of BEVA Congress last week. Mark Bowen, Associate Professor of Veterinary Internal Medicine at The University of Nottingham School of Veterinary Medicine and Science, becomes President Elect.Andrew said: "It is a privilege and an honour to take up the presidential reins for the next 12 months. It is unrealistic to expect to "change the world" in such a short time frame so the plan is to target certain areas, such as progressing New Safer Horse Rescue courses, strengthening BEVA's relationship with the BHA and moving forward with the regulation of Musculoskeletal Paraprofessionals. Not least it is a priority this year to make sure we keep aspiring vets realistically informed about future employment in our profession given the proliferation of undergraduate places available at UK and English speaking mainland European vet schools."
For further information visit www.beva.org.uk.
The RCVS has announced that it has accepted the resignation of council member Bob Partridge.
Bob, who had been an elected member of the RCVS Council since July 2006, tendered his resignation for personal reasons.
Peter Robinson will take up the vacated Council position, as he came next in the ballot in the 2013 election.
Novartis Animal Health has launched Onsior®, a coxib NSAID (non-steroidal anti-inflammatory drug) for the relief of pain and inflammation in both cats and dogs.
According to the company, NSAIDs traditionally inhibit both COX-2 and COX-1 enzymes which can result in common side effects involving the gastrointestinal tract and the kidneys. Onsior, however, targets the pain-causing COX-2 enzymes while sparing the protective actions of COX-1 and is the only coxib licensed for cats as well as dogs.
Novartis says tissue selectivity is a further benefit of Onsior. The drug travels rapidly through the bloodstream to the site of injury or irritation. It then concentrates at the point of inflammation, while exiting the bloodstream very quickly.
Dosed once daily, Novartis says Onsior has an excellent safety profile and fits different administration routes with pain and inflammatory indications, which are:
Kelly Doucette, DVM, Global Technical Services Manager with Novartis Animal Health said: "With the benefits of being tissue selective, sparing COX-1, and having a short blood half-life - as well as being approved for both cats and dogs - Onsior will stand out as the new pain reliever of choice for vets."
Folkert Kamphuis, COO Novartis Animal Health added: "Onsior covers multiple indications, works for cats and dogs, comes in two formulations - oral and injectable - and is very simple to dose, which allows veterinarians to use it as the cornerstone of pain management in their clinics. With this complete range, Onsior will offer veterinarians a convenient solution addressing all their different needs."
Amongst the speakers were Catherine Oxtoby MRCVS, Risk Manager at the Veterinary Defence Society, and Dr Huw Stacey, director of clinical services at Vets4Pets.
Dr Stacey explained how Vets4Pets and Companion Care practices are embracing a culture of sharing information when things don’t go according to plan in practice.
He said: "We all face challenges in the workplace, and this event focused on how different professions can share ideas and good practice and how they find solutions to any challenges.
"The culture of aviation and maritime is one of minimising risk and putting safety first, and it is fascinating to compare their approach to that found in medicine and veterinary.
"One common theme we discussed was the wellbeing of both professionals and patients or clients, with tiredness being at the top of the list of things that can negatively affect wellbeing and performance.
"Both aviation and maritime recognised that long shifts, particularly overnight, needed to be reduced in order to improve the outcome for everyone.
"In veterinary and human medicine, tiredness and long shifts are often worn as a badge of honour and being tired at work was something that should be admired, rather than addressed.
"But, tired vets are effectively neglecting themselves and their own wellbeing, which in turn leads to pets not receiving the best level of care in practice.
"This is something we’re taking seriously at Vets4Pets and Companion Care, and we’re currently looking at ways to decrease the risk of overworked and tired vets and vet nurses."
Another area of discussion was around the reporting of near misses and when things don’t go right, and how veterinary professionals need to identify and share the learnings from these events, not only within their practice, but with the wider profession too.
He said: "We need to continually emphasise the concept of a ‘just’ culture, to ensure our colleagues feel confident about reporting incidents open and honestly."
"It is not in the interests of the professional, the patient or the client to bottle things up, and at Vets4Pets and Companion Care we’re encouraging all of our practices to adopt the VDS VetSafe system, which provides a mechanism for sharing incident reports across the profession, enabling us all to learn from them to the benefit of our patients."
The five-part series, which is hosted on Elanco’s customer portal MyElanco.co.uk, covers topics including managing social media communities, how to build a presence using social media advertising and how to respond to new regulations around personal data.
According to a report on Bloomberg, Facebook is reported to be on track to have 32.6 million regular users in the UK despite its falling audience of younger users. Meanwhile Instagram's UK user base was believed to be 16.7 million at the end of 2017. Hence why 81% of small and medium businesses are reported to use some kind of social platform.
Elanco Customer Experience Manager Matthew Rowe said: "The global popularity of social media sites means people now expect businesses to have a social media presence and veterinary practices are no different.
"More veterinary practices are launching business profiles, recognising how vital it is to have a social presence so they can engage with their clients outside of the consultation room. But we realise that it can seem like an intimidating and complex process.
"The workshops have been created to help more vet practices get started with social media and gain more confidence to make the most out of it for the benefit of their business."
To watch the videos, register at MyElanco.co.uk and visit: https://www.myelanco.co.uk/CPD/video-workshop-part1
Themed 'Controlling Disease Threats at Home and from Abroad’, this year's conference will highlight the increasing importance of OVs in safeguarding the UK’s international trade and in protecting human health through disease surveillance and control.
The conference programme includes dedicated lecture streams aimed at large animal, small animal and equine practitioners. Improve says that lecture content has been tailored to cover areas of key relevance for more than 8,000 OVs due to revalidate their qualifications in March 2019. The programme also includes interactive workshops, including drop-in question and answer sessions offering practical advice and guidance on the revalidation process.
An exhibition of products and services for OVs runs alongside the conference.
David Babington MRCVS, Business Development Director at Improve, said: "This conference remains the only event dedicated to the needs of OVs. They receive industry updates from leading figures in the veterinary sector, attend lectures on OV work from experts and, in so doing, work towards their CPD revalidation requirements. We’re currently finalising a packed programme for this year’s conference and urge OVs to take advantage of our time-limited Early Bird offers and register without delay."
For more information on the Official Veterinarian Conference and Exhibition or to register visit: www.officialvet.com